Company:  PDL BIOPHARMA, INC. (PDLI)
Form Type:  10-Q
Filing Date:  8/8/2013 
CIK:  0000882104 
Address:  932 SOUTHWOOD BLVD 
City, State, Zip:  INCLINE VILLAGE, Nevada 89451 
Telephone:  775-832-8500 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$8.42  
Change: 
-0.06 (-0.71%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$1.35B
Description of Business
PDL BioPharma manages a portfolio of patents and royalty assets, consisting primarily of its Queen et al. antibody humanization patents and license agreements with various biotechnology and pharmaceutical companies. PDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases for which it receives significant royalty revenue. PDL is currently focused on intellectual property asset management, acquiring new income generating assets and maximizing value for its shareholders. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL was founded in 1986 and is headquartered in Incline Village, Nevada. In 2011, PDL initiated a strategy to bring in new income generating assets from the healthcare sector.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I. FINANCIAL INFORMATION
      ITEM 1. FINANCIAL STATEMENTS
        INCOME STATEMENT
        BALANCE SHEET
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF ...
      ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 4. CONTROLS AND PROCEDURES
    PART II. OTHER INFORMATION
      ITEM 1. LEGAL PROCEEDINGS
      ITEM 1A. RISK FACTORS
      ITEM 6. EXHIBITS
    SIGNATURES
  EXHIBIT 10.1
  EXHIBIT 12.1
    RATIO COMPUTATION
  EXHIBIT 31.1
    CERTIFICATIONS
  EXHIBIT 31.2
    CERTIFICATIONS
  EXHIBIT 32.1
    CERTIFICATION
  EXHIBIT 32.2
    CERTIFICATION
BROKERAGE PARTNERS